Product Information

NORTREL 7-7-7-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2221 per EA under NDC 00555901258. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Aug 30, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORTREL 7-7-7-28 TABLET

Norethindrone and Ethinyl Estradiol
$0.2221per EA

NDC

00555901258

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA075478

FDA Approved

8/30/2002

TE Code

AB

On Market Since

1/2/2003

Price Statistics

The NADAC for NORTREL 7-7-7-28 TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2221 per EA
All-time high$0.6865 (Apr 13, 2016)
All-time low$0.1916 (Nov 20, 2024)
52-week high$0.2962
52-week low$0.2044
Median price$0.4449
Average price$0.4437
Largest weekly change-36.8% (May 17, 2023)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+8.7%

1M

+2.8%

3M

-5.3%

6M

-13.4%

1Y

-22.0%

3Y

-36.7%

5Y

-43.6%

All

-65.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NORTREL 7-7-7-28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NORTREL 7-7-7-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2221 per EA (NDC 00555901258), effective Nov 18, 2026.

How has the price of NORTREL 7-7-7-28 TABLET changed over time?

Over the history we have for it, the NADAC for NORTREL 7-7-7-28 TABLET has declined 65.4%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NORTREL 7-7-7-28 TABLET?

Since Nov 28, 2013, the NADAC for NORTREL 7-7-7-28 TABLET has ranged from a low of $0.1916 (Nov 20, 2024) to a high of $0.6865 (Apr 13, 2016), with a median of $0.4449 per EA.

Are there cheaper alternatives to NORTREL 7-7-7-28 TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.1958 per EA — about 12% below NORTREL 7-7-7-28 TABLET.

Who manufactures NORTREL 7-7-7-28 TABLET?

NORTREL 7-7-7-28 TABLET (NDC 00555901258) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.